These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11575182

  • 61. Research councils unite to tackle antimicrobial resistance.
    Vet Rec; 2014 Jul 26; 175(4):79. PubMed ID: 25059955
    [No Abstract] [Full Text] [Related]

  • 62. 2-pyridones.
    Harper JF.
    Lancet; 1995 Jul 15; 346(8968):186-7. PubMed ID: 7603255
    [No Abstract] [Full Text] [Related]

  • 63. The medicinal chemistry of anti-infectious agents.
    González-Bello C.
    Curr Top Med Chem; 2008 Jul 15; 8(7):532. PubMed ID: 18473881
    [No Abstract] [Full Text] [Related]

  • 64. Combatting Infections with Nanomedicine.
    Fang RH, Zhang L.
    Adv Healthc Mater; 2018 Jul 15; 7(13):e1800392. PubMed ID: 29995335
    [No Abstract] [Full Text] [Related]

  • 65. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Jul 15; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 66. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 15; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 67. [Recent development in quinolone compounds antitumor quinolones].
    Yang YS, Zhao SR, Ji RY, Chen KX.
    Yao Xue Xue Bao; 1998 Dec 15; 33(2):157-60. PubMed ID: 11938953
    [No Abstract] [Full Text] [Related]

  • 68. Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
    Sato K, Hoshino K, Mitsuhashi S.
    Prog Drug Res; 1992 Dec 15; 38():121-32. PubMed ID: 1319080
    [No Abstract] [Full Text] [Related]

  • 69. Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.
    Inagaki H, Takahashi H, Takemura M.
    Bioorg Med Chem Lett; 2004 Oct 18; 14(20):5193-8. PubMed ID: 15380226
    [Abstract] [Full Text] [Related]

  • 70. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Oct 18; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 71. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 18; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 72. [Recent development in quinolone compounds antitumor quinolones].
    Yang YS, Zhao SR, Ji RY, Chen KX.
    Yao Xue Xue Bao; 1998 Dec 18; 33(2):157-60. PubMed ID: 11938953
    [No Abstract] [Full Text] [Related]

  • 73. Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
    Sato K, Hoshino K, Mitsuhashi S.
    Prog Drug Res; 1992 Dec 18; 38():121-32. PubMed ID: 1319080
    [No Abstract] [Full Text] [Related]

  • 74. Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.
    Inagaki H, Takahashi H, Takemura M.
    Bioorg Med Chem Lett; 2004 Oct 18; 14(20):5193-8. PubMed ID: 15380226
    [Abstract] [Full Text] [Related]

  • 75. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Oct 18; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 76. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 18; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 77. [Recent development in quinolone compounds antitumor quinolones].
    Yang YS, Zhao SR, Ji RY, Chen KX.
    Yao Xue Xue Bao; 1998 Dec 18; 33(2):157-60. PubMed ID: 11938953
    [No Abstract] [Full Text] [Related]

  • 78. Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
    Sato K, Hoshino K, Mitsuhashi S.
    Prog Drug Res; 1992 Dec 18; 38():121-32. PubMed ID: 1319080
    [No Abstract] [Full Text] [Related]

  • 79. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J.
    J Antimicrob Chemother; 2003 May 18; 51(5):1109-17. PubMed ID: 12697644
    [Abstract] [Full Text] [Related]

  • 80. [The evolution of quinolone: from nalidixic acid to the quinolones of the third generation].
    Petersen U.
    Pharm Unserer Zeit; 2001 May 18; 30(5):376-81. PubMed ID: 11575173
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.